MedPath

A CROSS-SECTIONAL STUDY ON PRURITUS IN PATIENTS WITH CUTANEOUS MANIFESTATIONS OF HEMATOLOGICAL MALIGNANCIES AND ITS ASSOCIATION WITH SERUM IL-13 LEVELS.

Not Applicable
Conditions
Health Condition 1: L298- Other pruritus
Registration Number
CTRI/2024/02/062463
Lead Sponsor
IDHI P M
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All diagnosed patients of hematological malignancies.

Exclusion Criteria

1.Patients with hematological malignancies who also have dermatological disorders that are known to be associated with pruritus such as atopic dermatitis, allergic contact dermatitis, prurigo nodularis, chronic urticaria.

2. Patients testing positive for HIV 1 & 2, Hepatitis A and Hepatitis B.

3. Patients with diagnosed drug reactions.

4. Pregnant and lactating women

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath